Home › Funds › Capital Group › Capital Group Core Balanced ETF
Fund family: Capital Group · Filed by Capital Group Core Balanced ETF (CIK 1970533) · SEC series S000080721
Ticker: CGBL (C000243250)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 937 with, 94 against, 2 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 19 FOR, 76 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Capital Group | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.2% | 901 | 96.6% | 98,284 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 55 | 1.3% | 2,130 |
Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Capital Group funds on 3 items (0.3% of the 995 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Capital Group funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| ConocoPhillips | 2026-05-12 | Shareholder Stockholder Proposal - Independent Board Chairman. | Against | FOR — 12 of 14 Capital Group funds | For | Not approved, 28.0% support |
| Amazon.com, Inc. | 2026-05-20 | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION | Against | FOR — 17 of 24 Capital Group funds | Against | Approved, 94.0% support |
| UnitedHealth Group Incorporated | 2026-06-01 | Election of Directors: Scott Gottlieb, M.D. | Against | FOR — 13 of 19 Capital Group funds | Against | Elected, 93.0% support |
Download all 3 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 85.2% of this fund’s 1,033 such votes could be given a sector; the other 153 (14.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 216 | 28 | 13.0% |
| Technology | 193 | 31 | 16.1% |
| Finance | 161 | 15 | 9.3% |
| Industrials | 132 | 7 | 5.3% |
| Health Care | 95 | 9 | 9.5% |
| Consumer Staples | 31 | 1 | 3.2% |
| Telecommunications | 21 | 1 | 4.8% |
| Energy | 16 | 1 | 6.3% |
| Utilities | 15 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 719 | 0 |
| Audit-related | 72 | 0 |
| Corporate Governance | 67 | 32 |
| Say-on-Pay | 60 | 0 |
| Compensation | 36 | 3 |
| Environment or Climate | 25 | 25 |
| Other Social Issues | 23 | 23 |
| Capital Structure | 15 | 0 |
| Human Rights or Human Capital/workforce | 8 | 8 |
| Extraordinary Transactions | 5 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Broadcom Inc. | April 20, 2026 | $235M | 10 | 0 |
| Taiwan Semiconductor Manufacturing Co., Ltd. | June 4, 2026 | $188M | 3 | 0 |
| Meta Platforms, Inc. | May 27, 2026 | $143M | 22 | 9 |
| Microsoft Corporation | December 5, 2025 | $136M | 21 | 6 |
| ATI Inc. | May 14, 2026 | $81M | 5 | 0 |
| Philip Morris International Inc. | May 6, 2026 | $80M | 13 | 1 |
| Vertex Pharmaceuticals Incorporated | May 13, 2026 | $80M | 14 | 1 |
| Apple Inc. | February 24, 2026 | $72M | 12 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| January 15, 2026 | Micron Technology, Inc. | SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | For | Against |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
1,035 ballot items at 74 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Capital Group Core Balanced ETF (CGBL) voted at 74 shareholder meetings of 73 companies, on 1,035 ballot items in all. Where management made a recommendation, the fund followed it on 90.7% of the items and voted against it 94 times. Its most frequent area of disagreement was corporate governance (32 of its votes against management). It voted FOR 20.0% of the 95 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Capital Group's funds as a whole (98.2% against 96.6%). It voted differently from most Capital Group funds on 3 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.